Farco-Pharma GmbH – Trademark Portfolio

Entity Type: 99

Farco-Pharma GmbH holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 2 are pending. Notable registered marks include GLYDO, INSTILLA, and INSTILLAGEL. The owner is based in Cologne 80, Mulheim.

Cologne 80, Mulheim 5000 , DE

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Farco-Pharma GmbH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Farco-Pharma GmbH have?

Farco-Pharma GmbH has 8 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending, 2 cancelled.

What trademark classes does Farco-Pharma GmbH file in?

Farco-Pharma GmbH files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Farco-Pharma GmbH's most well-known trademarks?

Farco-Pharma GmbH's registered trademark portfolio includes well-known marks such as GLYDO, INSTILLA, and INSTILLAGEL. These are among 3 currently registered trademarks in the portfolio.

What is Farco-Pharma GmbH's trademark registration success rate?

Farco-Pharma GmbH has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 2 applications are pending review.